Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)
China · Delayed Price · Currency is CNY 9.58
+0.05 (0.52%)
Sep 14, 2026, 11:29 AM CST
Shenzhen YHLO Biotech Market Cap
Shenzhen YHLO Biotech has a market cap or net worth of 5.45 billion as of September 11, 2026. Its market cap has decreased by -37.03% in one year.
Market Cap
5.45B
Enterprise Value
5.72B
Revenue
1.89B
Ranking
n/a
PE Ratio
86.94
Stock Price
9.58
ChartMarket Cap Chart
Since May 17, 2021, Shenzhen YHLO Biotech's market cap has decreased from 25.92B to 5.45B, a decrease of -78.99%. That is a compound annual growth rate of -25.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 5.45B | -32.89% |
| Dec 31, 2025 | 8.11B | -9.95% |
| Dec 31, 2024 | 9.01B | -30.65% |
| Dec 29, 2023 | 12.99B | 16.62% |
| Dec 30, 2022 | 11.14B | -20.38% |
| Dec 31, 2021 | 13.99B | -46.02% |
| May 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. | 6.77B |
| Edan Instruments | 6.48B |
| Sino Medical Sciences Technology | 6.40B |
| Xiangyu Medical Co.,Ltd | 5.77B |
| BMC Medical | 5.44B |
| Shanghai Sanyou Medical | 4.70B |
| Shenzhen Lifotronic Technology | 4.64B |
| Getein Biotech | 4.61B |